BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8065570)

  • 1. Three-dimensional surface display of brain perfusion with 123I-IMP in Parkinson's disease.
    Tachibana H; Kawabata K; Tomino Y; Sugita M; Fukuchi M
    Neuroradiology; 1994 May; 36(4):276-80. PubMed ID: 8065570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Three-dimensional surface display with 123I-IMP brain perfusion imaging in patients with dementia].
    Tomino Y; Tachibana H; Sugita M
    Rinsho Shinkeigaku; 1994 Apr; 34(4):318-25. PubMed ID: 8026123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain perfusion imaging in Parkinson's disease and Alzheimer's disease demonstrated by three-dimensional surface display with 123I-iodoamphetamine.
    Tachibana H; Kawabata K; Tomino Y; Sugita M; Fukuchi M
    Dementia; 1993; 4(6):334-41. PubMed ID: 8136897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral blood flow and dementia in Parkinson's disease.
    Kawabata K; Tachibana H; Sugita M
    J Geriatr Psychiatry Neurol; 1991; 4(4):194-203. PubMed ID: 1789907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontal assessment battery and brain perfusion image in Parkinson's disease.
    Matsui H; Udaka F; Miyoshi T; Hara N; Tamura A; Oda M; Kubori T; Nishinaka K; Kameyama M
    J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):41-5. PubMed ID: 16449760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-isopropyl-p- 123I iodoamphetamine single photon emission computed tomography study of Parkinson's disease with dementia.
    Matsui H; Udaka F; Miyoshi T; Hara N; Tamura A; Oda M; Kubori T; Nishinaka K; Kameyama M
    Intern Med; 2005 Oct; 44(10):1046-50. PubMed ID: 16293914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional surface display using 123I-IMP in a case of motor neuron disease with dementia.
    Okuda B; Kawabata K; Tachibana H; Sugita M; Fukuchi M
    Jpn J Psychiatry Neurol; 1993 Sep; 47(3):599-602. PubMed ID: 8301875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of Parkinson's disease using 123I-IMP SPECT].
    Hayashi H; Odano I; Nishihara M; Higuchi S; Sakai K; Ishikawa A
    Kaku Igaku; 1989 Nov; 26(11):1405-15. PubMed ID: 2615027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of Parkinson's disease and related syndromes using 123I-IMP-SPECT with the ARG method].
    Kageyama H; Kikuchi S; Tashiro K
    Nihon Rinsho; 1997 Jan; 55(1):238-42. PubMed ID: 9014457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative regional cerebral blood flow study with 123I-IMP in patients with dementia and in patients with poor activities of daily living].
    Iwamiya T
    Kaku Igaku; 1993 Nov; 30(11):1341-51. PubMed ID: 8277596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPECT findings in Parkinson's disease associated with dementia.
    Sawada H; Udaka F; Kameyama M; Seriu N; Nishinaka K; Shindou K; Kodama M; Nishitani N; Okumiya K
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):960-3. PubMed ID: 1431961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Mito Y; Yoshida K; Yabe I; Makino K; Hirotani M; Tashiro K; Kikuchi S; Sasaki H
    Clin Neurol Neurosurg; 2005 Aug; 107(5):396-403. PubMed ID: 16023534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal cortical hypoperfusion in corticobasal degeneration demonstrated by three-dimensional surface display with 123I-IMP: a possible cause of apraxia.
    Okuda B; Tachibana H; Takeda M; Kawabata K; Sugita M; Fukuchi M
    Neuroradiology; 1995 Nov; 37(8):642-4. PubMed ID: 8748895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 123I-N-isopropyl-amphetamine single photon emission computed tomography as a brain imaging technique in dementia.
    Kaiser-Martini R; Kessler C; Strauss L; Sinn H; Kohlmeyer K
    Acta Radiol Suppl; 1986; 369():460-2. PubMed ID: 2980527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cerebral blood flow in catatonic schizophrenia.
    Satoh K; Suzuki T; Narita M; Ishikura S; Shibasaki M; Kato T; Takahashi S; Fukuyama H; Ohnishi H; Morita R
    Psychiatry Res; 1993 Dec; 50(4):203-16. PubMed ID: 8177921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's disease: a comparison with dementia of the Alzheimer type.
    Spampinato U; Habert MO; Mas JL; Bourdel MC; Ziegler M; de Recondo J; Askienazy S; Rondot P
    J Neurol Neurosurg Psychiatry; 1991 Sep; 54(9):787-92. PubMed ID: 1955897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of cognitive function and regional cerebral blood flow in Parkinson's disease by 123I-IMP SPECT].
    Yamamoto K
    Rinsho Shinkeigaku; 1992 Jan; 32(1):1-7. PubMed ID: 1628430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of the cognitive function and the duration of the illness with the regional cerebral blood flow in the patients with Parkinson's disease: objective evaluation using stereotactic extraction estimation analysis in 123I-IMP SPECT].
    Sakai T; Kuzuhara S
    No To Shinkei; 2006 Jan; 58(1):29-37. PubMed ID: 16482919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cerebral blood flow study with 123I-IMP in patients with degenerative dementia.
    Ohnishi T; Hoshi H; Nagamachi S; Jinnouchi S; Futami S; Watanabe K; Mitsuyama Y
    AJNR Am J Neuroradiol; 1991; 12(3):513-20. PubMed ID: 2058505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT and planar brain imaging in crack abuse: iodine-123-iodoamphetamine uptake and localization.
    Weber DA; Franceschi D; Ivanovic M; Atkins HL; Cabahug C; Wong CT; Susskind H
    J Nucl Med; 1993 Jun; 34(6):899-907. PubMed ID: 8509856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.